CA 15-3 is a glycoprotein most commonly measured as a tumour marker in patients with breast cancer.
CA 15-3 is not suitable as a screening test for the primary diagnosis of tumours.
Cancer Antigen 15-3
If overnight - Frozen
CA 15-3 lacks sensitivity and specificity for any cancer and therefore it should not be used for screening or diagnostic purposes. However, CA 15-3 may be monitored in a patient with a known CA15-3 secreting tumour (usually breast cancer) to assess for both response to treatment and recurrence or progression of known disease.
0 – 24 kIU/L
Paramagnetic particle, chemiluminescent immunoassay performed on Beckman Coulter DxI 800
$19.99 (Exclusive of GST)
"*" indicates required fields